DIA-US FDA-ANDA WORKSHOP: Present And Future Perspectives On Generic Drug Life Cycle Management

Peter Capella, PHD

Lifecycle Drug Products, Office of Pharmaceutical Quality, CDER, FDA , United States

Director, Division of Immediate and Modified Release Drug Products, Office of

Utpal Munshi, PHD

Office of Generic Drugs, CDER, FDA, United States

Division Director, Division of Bioequivalence I (DBI), Office of Bioequivalence,